Riskpilot← Back to searchSign inGet full accessClearlii AB
ABActiveOrg 5568693898Sollentunavägen 309 BvRetail sale of medical and orthopaedic goods · NACE 4774Est. 20115-9 employees
Revenue 2024
SEK 55,3M
+15% vs 2023
EBITDA margin
7.9%
-9% vs 2023
Equity ratio
70.6%
Financial strength
Net profit 2024
SEK 3,1M
+4% vs 2023
| Revenue | SEK 55,3M | +15% |
| EBITDA | SEK 4,4M | -9% |
| Net profit | SEK 3,1M | +4% |
| Total assets | SEK 34,5M | +14% |
| Equity | SEK 24,4M | +15% |
| Employees | — | — |
Legal name
Clearlii AB
Org number
5568693898
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
29 oktober 2011
Share capital
SEK 169 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets ändamål är att sälja kontaktlinser och närliggande produkter.
Address
Sollentunavägen 309 Bv
Phone
+46840919200
Email
info@clearlii.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 32 385 | 37 556 | 34 212 | 33 207 | 44 085 | 48 260 | 55 308 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −613 | −1 453 | −79 | 1 359 | 2 632 | 3 789 | 4 868 | 5 058 | 4 834 | 4 377 |
| Depreciation & amort. | −393 | −521 | −741 | −1 036 | −1 159 | −1 289 | −1 282 | −1 072 | −889 | −554 |
| EBIT | −1 006 | −1 974 | −820 | 323 | 1 473 | 2 500 | 3 586 | 3 986 | 3 945 | 3 823 |
| Net financials | −227 | −6 | −107 | −270 | −354 | −320 | −297 | −254 | −118 | −211 |
| Profit before tax | −1 234 | −1 980 | −927 | 53 | 1 120 | 2 180 | 2 739 | 3 882 | 3 828 | 4 012 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −343 | −816 | −805 | −867 |
| Net profit | −1 234 | −1 980 | −927 | 53 | 1 120 | 2 180 | 2 396 | 3 066 | 3 023 | 3 145 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 911 | 6 643 | 7 991 | 14 554 | 16 415 | 15 597 | 18 325 | 25 482 | 30 398 | 34 513 |
| Equity | 4 287 | 5 307 | 4 380 | 4 433 | 5 553 | 7 733 | 10 129 | 18 195 | 21 218 | 24 363 |
| Long-term debt | 0 | 0 | 1 667 | 1 222 | 1 750 | 1 250 | 750 | 250 | 0 | 0 |
| Short-term debt | 624 | 1 336 | 1 944 | 8 898 | 9 112 | 6 614 | 6 896 | 6 637 | 8 780 | 10 150 |
| Total debt | 624 | 1 336 | 3 611 | 10 120 | 10 862 | 7 864 | 7 646 | 6 887 | 8 780 | 10 150 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20152024
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
20152024
Return on equity
12.9%
This company
18.4%
Market median
+30% vs market
20152024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20152024
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20152024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AK | Audit | 2025 | — | — |
CA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clearlii AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan P K Swanson Carlström | Chief Executive Officer | 0 companies |
| A Kornelia B Wall Andersson | Audit | 0 companies |
| Christian Asmussen | Chief Executive Officer | 0 companies |
| Banafsheh Susanne Najafi Amirkiasar | Board of Directors | 0 companies |
| Navid Rostam Khesal | Board of Directors | 0 companies |
| Gabriella Rosén | Board of Directors | 0 companies |
| Martin Jan Kristian Arwin | Board of Directors | 0 companies |
| Patrik Kenneth Rosén | Board of Directors | 0 companies |
| Karl Magnus Lundin | Chairman | 0 companies |